Belzutifan+pembrolizumab post-surgery helps kidney cancer patients at high risk for relapse stay cancer-free longer
Patients with a common form of kidney cancer called clear cell renal cell carcinoma (ccRCC) who have a high risk of recurrence after surgery showed significantly improved disease-free survival when treated with an oral combination ...
Mar 2, 2026
0
0









